SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011927
Filing Date
2018-05-08
Accepted
2018-05-08 17:11:35
Documents
42
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q reta-10q_20180331.htm 10-Q 946859
2 EX-31.1 reta-ex311_9.htm EX-31.1 18954
3 EX-31.2 reta-ex312_6.htm EX-31.2 18591
4 EX-32.1 reta-ex321_11.htm EX-32.1 10178
5 EX-32.2 reta-ex322_12.htm EX-32.2 10168
  Complete submission text file 0001564590-18-011927.txt   2849117

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT reta-20180331.xml EX-101.INS 366288
7 XBRL TAXONOMY EXTENSION SCHEMA reta-20180331.xsd EX-101.SCH 28268
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20180331_cal.xml EX-101.CAL 30625
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20180331_def.xml EX-101.DEF 94423
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20180331_lab.xml EX-101.LAB 227190
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20180331_pre.xml EX-101.PRE 165158
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 18815720
SIC: 2834 Pharmaceutical Preparations